Blonanserin versus haloperidol in Japanese patients with schizophrenia: A phase 3, 8-week, double-blind, multicenter, randomized controlled study.

Philip D HarveyHiroshi NakamuraMitsukuni Murasaki

Published in: Neuropsychopharmacology reports (2019)

Blonanserin is as effective as haloperidol for the treatment of schizophrenia. Blonanserin is more effective for negative symptoms with a lower risk of extrapyramidal symptoms compared with haloperidol.

Keyphrases

double blind
placebo controlled
clinical trial
phase iii
phase ii
bipolar disorder
study protocol
sleep quality
randomized controlled trial
depressive symptoms
smoking cessation
replacement therapy